0001504167-15-000003.txt : 20150319 0001504167-15-000003.hdr.sgml : 20150319 20150318173357 ACCESSION NUMBER: 0001504167-15-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150319 DATE AS OF CHANGE: 20150318 EFFECTIVENESS DATE: 20150319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioPharmX Corp CENTRAL INDEX KEY: 0001504167 STANDARD INDUSTRIAL CLASSIFICATION: CONSTRUCTION SPECIAL TRADE CONTRACTORS [1700] IRS NUMBER: 593843182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-215847 FILM NUMBER: 15711028 BUSINESS ADDRESS: STREET 1: 1098 HAMILTON COURT CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-889-5020 MAIL ADDRESS: STREET 1: 1098 HAMILTON COURT CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: THOMPSON DESIGNS INC DATE OF NAME CHANGE: 20101022 D/A 1 primary_doc.xml X0707 D/A LIVE 0001504167 BioPharmX Corp 1098 HAMILTON COURT MENLO PARK CA CALIFORNIA 94025 650-889-5020 DELAWARE THOMPSON DESIGNS INC Corporation true 2014 JAMES PEKARSKY 1098 HAMILTON COURT MENLO PARK CA CALIFORNIA 94025 Executive Officer Director CEO and CFO ANJA KRAMMER 1098 HAMILTON COURT MENLO PARK CA CALIFORNIA 94025 Executive Officer Director President KIN CHAN 1098 HAMILTON COURT MENLO PARK CA CALIFORNIA 94025 Executive Officer Executive Vice President of R&D MICHAEL HUBBARD 1098 HAMILTON COURT MENLO PARK CA CALIFORNIA 94025 Director PING WANG 1098 HAMILTON COURT MENLO PARK CA CALIFORNIA 94025 Director Pharmaceuticals Decline to Disclose 06b true 0001504167-14-000100 2014-04-11 false true true true false 0 18621799 7869775 10752024 Amount sold includes the sale of Series A Stock. Total remaining to be sold includes warrant shares that may be purchased by the respective holders multiplied by the exercise price. Issuer will not receive any cash proceeds unless warrants are exercised. false 51 0 227228 Finders Fees were paid in shares of Series A Preferred Stock at the value of $1.85 per share and are included in the amount listed in Item 13 under Total Amount Sold. 0 false BioPharmX Corp /s/James Pekarsky James Pekarsky CEO and CFO 2015-03-18